Planning a deliberate stop If you and your clinician decide to end treatment, the slow clearance is worth building into the plan rather than discovering afterwards
However, science has proven that its not nearly as cut and dry as that
The full TRIUMPH program spans eight Phase 3 trials plus TRIUMPH-CVOT, enrolling more than 5,800 participants in the core weight-management trials and roughly 10,000 in the cardiovascular outcomes trial
127 USP14 and USP2 deubiquitinate fatty acid synthase (FASN), a key enzyme in lipogenesis, aggravating hepatic steatosis and insulin resistance
This information does not and should not replace treatment from a medical professional
Diabetes 55 , 33873393 (2006)